Literature DB >> 1506809

Drug-induced hepatic injury: an analysis of 1100 cases reported to the Danish Committee on Adverse Drug Reactions between 1978 and 1987.

H Friis1, P B Andreasen.   

Abstract

The Danish Committee on Adverse Drug Reactions received 1100 reports of suspected drug-induced hepatic injury during the decade 1978-1987. The causal relationship between drug and hepatic injury was classified as definite in 57 (5.2%) reports, probable in 989 (89.9%) reports, possible in 50 (4.5%) reports and unclassifiable in four (0.4%) reports. Hepatic injuries accounted for 5.9% of all adverse drug reactions reported, and 14.7% of the lethal adverse drug reactions. A total of 47.2% were classified as acute cytotoxic, 16.2% as acute cholestatic and 26.9% as abnormal hepatic function. In 52 (4.7%) cases the hepatic injury was lethal; only 14 (1.3%) cases were chronic. Halothane accounted for 25% of the cases. The incidence of halothane-induced hepatic injury is decreasing, and only one lethal case has been reported since 1981. Next to halothane, sulfasalazine was the drug most often suspected during the last 2 years of the decade. Based on consumption data, the incidence of hepatic injury due to sulindac was estimated to be 18-fold higher than that due to ibuprofen. Paracetamol was reported to induce acute cytotoxic as well as cholestatic reactions in non-alcoholic subjects taking therapeutic doses.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1506809     DOI: 10.1111/j.1365-2796.1992.tb00562.x

Source DB:  PubMed          Journal:  J Intern Med        ISSN: 0954-6820            Impact factor:   8.989


  25 in total

1.  Indications for referral and assessment in adult liver transplantation: a clinical guideline. British Society of Gastroenterology.

Authors:  J Devlin; J O'Grady
Journal:  Gut       Date:  1999-12       Impact factor: 23.059

2.  Evaluation of prognostic markers in severe drug-induced liver disease.

Authors:  Bo Li; Zhi Wang; Jian-Jiang Fang; Ci-Yi Xu; Wei-Xing Chen
Journal:  World J Gastroenterol       Date:  2007-01-28       Impact factor: 5.742

Review 3.  Drug-induced cholestasis.

Authors:  Manmeet S Padda; Mayra Sanchez; Abbasi J Akhtar; James L Boyer
Journal:  Hepatology       Date:  2011-04       Impact factor: 17.425

4.  Massive naproxen overdose with serial serum levels.

Authors:  Suad A Al-Abri; Ilene B Anderson; Fatehi Pedram; Jennifer M Colby; Kent R Olson
Journal:  J Med Toxicol       Date:  2015-03

Review 5.  An updated review on drug-induced cholestasis: mechanisms and investigation of physicochemical properties and pharmacokinetic parameters.

Authors:  Kyunghee Yang; Kathleen Köck; Alexander Sedykh; Alexander Tropsha; Kim L R Brouwer
Journal:  J Pharm Sci       Date:  2013-05-07       Impact factor: 3.534

6.  The natural history of histologically proved drug induced liver disease.

Authors:  P G Aithal; C P Day
Journal:  Gut       Date:  1999-05       Impact factor: 23.059

7.  Risk of Acute Liver Failure in Patients With Drug-Induced Liver Injury: Evaluation of Hy's Law and a New Prognostic Model.

Authors:  Vincent Lo Re; Kevin Haynes; Kimberly A Forde; David S Goldberg; James D Lewis; Dena M Carbonari; Kimberly B F Leidl; K Rajender Reddy; Melissa S Nezamzadeh; Jason Roy; Daohang Sha; Amy R Marks; Jolanda De Boer; Jennifer L Schneider; Brian L Strom; Douglas A Corley
Journal:  Clin Gastroenterol Hepatol       Date:  2015-06-27       Impact factor: 11.382

Review 8.  Adverse reactions to targeted and non-targeted chemotherapeutic drugs with emphasis on hypersensitivity responses and the invasive metastatic switch.

Authors:  Brian A Baldo; Nghia H Pham
Journal:  Cancer Metastasis Rev       Date:  2013-12       Impact factor: 9.264

9.  Acute and clinically relevant drug-induced liver injury: a population based case-control study.

Authors:  Francisco J de Abajo; Dolores Montero; Mariano Madurga; Luis A García Rodríguez
Journal:  Br J Clin Pharmacol       Date:  2004-07       Impact factor: 4.335

Review 10.  Drug-induced hepatic disorders. Incidence, management and avoidance.

Authors:  M Døssing; J Sonne
Journal:  Drug Saf       Date:  1993-12       Impact factor: 5.606

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.